Please use this identifier to cite or link to this item: http://20.193.157.4:9595/xmlui/handle/123456789/1162
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSaurabh G Sadekar, SN Bentoor.-
dc.date.accessioned2019-11-06T12:14:27Z-
dc.date.available2019-11-06T12:14:27Z-
dc.date.issued2016-
dc.identifier.issn22293809-
dc.identifier.urihttp://hdl.handle.net/123456789/1162-
dc.description.abstractThe introduction of effective highly active antiretroviral therapy (HAART) in the mid 1990s lead to the marked reduction in the morbidity and mortality from human immunodeficiency virus (HIV) infection. Increasing life expectancy, an aging population, and high rates of smoking have lead to concerns of the health of HIV infected individuals in the long run. Metabolic effects of HIV infection such as hypertriglyceridemia are well defined and side effects of HAART such as dyslipidemia and were described soon after its introduction.en_US
dc.language.isoenen_US
dc.publisherBLDE(Deemed to be University)en_US
dc.subjectHIV, LDL, HDL, antiretroviral drugs.en_US
dc.titleStudy of lipid profile in HIV/AIDS patients on antiretroviral therapy.en_US
dc.typeArticleen_US
Appears in Collections:Faculty of General Medicine

Files in This Item:
File Description SizeFormat 
A1016.pdf783.3 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.